Cipher Pharma (CPHR) Misses Q1 EPS by 6c

Cipher Pharma (NASDAQ: CPHR) reported Q1 EPS of ($0.10), $0.06 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $10.72 million.

For earnings history and earnings-related data on Cipher Pharma (CPHR) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• PolyPid Ltd. (PYPD) Tops Q2 EPS by 5c
• Avino Silver & Gold Mines (ASM) Misses Q2 EPS by 4c